15 research outputs found
Protein kinase CK2 in hematologic malignancies: reliance on a pivotal cell survival regulator by oncogenic signaling pathways
No full textLeukemic B cells from patients with chronic lymphocytic leukemia show anomalous Lyn tyrosine kinase which contributes to defective apoptosis.
No full textMultiple myeloma cells survival and proliferation rely on high levels and activity of the serine-threonine kinase CK2.
No full textCK2 serine-threonine kinase controls multiple myeloma cells survival and proliferation and its selective block leads to growth arrest, apoptosis and altered NFKB signaling
No full textMultiple myeloma cells survival and proliferation rely on high levels and activity of the serine-threonine kinase CK2.
No full textLeukemic B Cells from Patients with Chronic Lymphocytic Leukemia Show Anomalous Lyn Tyrosine Kinase which Contributes to Defective Apoptosis.
No full textChronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis
Full text linkRole of protein kinasi CK2 in the retinoic acid-induced differentiation of acute promyelocytic leukemia cells
No full textRole of protein kinase CK2 in the retinoic acid-induced differentiation of acute promyelocytic leukemia cells.
No full textInhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity
No full text
